Cited by 339Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Plant Pathogen Control

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical Candida albicans Strains

Open access

Franz, Renate, Kelly, Steven L., Lamb, David C., Kelly, Diane E., Ruhnke, Markus, Morschhäuser, Joachim·1998·Antimicrobial Agents and Chemotherapy

DOI 10.1128/aac.42.12.3065PMC PMC106000

Open this paper in CoChat — free account Open PDF

Abstract

From each of two AIDS patients with oropharyngeal candidiasis, five Candida albicans isolates from recurrent episodes of infection which became gradually resistant against fluconazole during antimycotic treatment were analyzed for molecular changes responsible for drug resistance. In both patients, a single C. albicans strain was responsible for the recurrent infections, but the CARE-2 fingerprint pattern of the isolates exhibited minor genetic alterations, indicating that microevolution of the strains took place during fluconazole therapy. In the isolates from patient 1, enhanced mRNA levels of the MDR1 gene, encoding a multiple drug resistance protein from the superfamily of major facilitators, and constitutive high expression of the ERG11 gene, coding for the drug target enzyme sterol 14alpha-demethylase, correlated with a stepwise development of fluconazole resistance. The resistant strains exhibited reduced accumulation of fluconazole and, for the last in the series, a slight increase in drug needed to inhibit sterol 14alpha-demethylation in vitro. In the isolates from patient 2, increased MDR1 mRNA levels and the change from heterozygosity to homozygosity for a mutant form of the ERG11 gene correlated with continuously decreased drug susceptibility. In this series, reduced drug accumulation and increased resistance in the target enzyme activity, sterol 14alpha-demethylase, were observed. These results demonstrate that different molecular mechanisms contribute to a gradual development of fluconazole resistance in C. albicans.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/aac.42.12.3065

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Isogenic strain construction and gene mapping in Candida albicans.
Fonzi, W. A., & Irwin, M. Y. (1993) · Genetics · doi:10.1093/genetics/134.3.717 · Cited by 1,695
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 880
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene
Sanglard, D., Ischer, F., Monod, M., & Bille, J. (1997) · Microbiology · doi:10.1099/00221287-143-2-405 · Cited by 587
Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals
Prasad, R., De Wergifosse, P., Goffeau, A., & Balzi, E. (1995) · Current Genetics · doi:10.1007/bf00352101 · Cited by 486
Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents
Sanglard, D., Ischer, F., Koymans, L. M. H., & Billé, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465
Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors
Sanglard, D., Ischer, F., Monod, M., & Billé, J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2300 · Cited by 402
Resistance to fluconazole and cross‐resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6‐desaturation
Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351
Self-citation

Flagged first, then by citations

Show all 38 references

Research works printed but not linked: 2

Ausubel F. M. Brent R. Kingston R. E. Moore D. D. Seidman J. G. Smith J. A. Struhl K. Current protocols in molecular biology. 1989 John Wiley & Sons Inc. New York N.Y
Odds F. C. Candida and candidosis: a review and bibliography. 1988 Bailliere Tindall London United Kingdom

Sorted by citations

Items 101–200 of 339

The biodiversity of microbial cytochromes P450
Kelly, S. L., Lamb, D. C., Jackson, C. J., Warrilow, A. G. S., & Kelly, D. E. (2003) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/s0065-2911(03)47003-3 · Cited by 63
Self-citation
A Candida albicans Petite Mutant Strain with Uncoupled Oxidative Phosphorylation Overexpresses MDR1 and Has Diminished Susceptibility to Fluconazole and Voriconazole
Cheng, S., Clancy, C. J., Nguyen, K. T., Clapp, W., & Nguyen, M. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00182-07 · Cited by 62
Genome-Wide Single-Nucleotide Polymorphism Map for Candida albicans
Forche, A., Magee, P. T., Magee, B. B., & May, G. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.3.705-714.2004 · Cited by 62
The Evolution of Azole Resistance in Candida albicans Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions
Warrilow, A. G., Nishimoto, A. T., Parker, J. E., Price, C. L., Flowers, S. A., Kelly, D. E., Rogers, P. D., & Kelly, S. L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02586-18 · Cited by 60
Self-citation
Antifungal Resistance Among Candida Species
Klepser, M. E. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.12.124s.34511 · Cited by 61
Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing
Wang, H., Kong, F., Sorrell, T. C., Wang, B., McNicholas, P., Pantarat, N., Ellis, D., Xiao, M., Widmer, F., & Chen, S. C. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-167 · Cited by 58
Functional Similarities and Differences between Candida albicans Cdr1p and Cdr2p Transporters
Gauthier, C., Weber, S., Alarco, A., Alqawi, O., Daoud, R., Georges, E., & Raymond, M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1543-1554.2003 · Cited by 59
Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients
Maebashi, K., Niimi, M., Kudoh, M., Fischer, F. J., Makimura, K., Niimi, K., Piper, R., Uchida, K., Arisawa, M., Cannon, R. D., et al. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.527 · Cited by 60
Drug-Induced Regulation of the MDR1 Promoter in Candida albicans
Harry, J. B., Oliver, B. G., Song, J. L., Silver, P. M., Little, J. T., Choiniere, J., & White, T. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2785-2792.2005 · Cited by 58
Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance
Keniya, M. V., Fleischer, E., Klinger, A., Cannon, R. D., & Monk, B. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126350 · Cited by 58
Host versus in vitro signals and intrastrain allelic differences in the expression of a Candida albicans virulence gene
Staib, P., Kretschmar, M., Nichterlein, T., Hof, H., & Morschhäuser, J. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02967.x · Cited by 58
RETRACTED ARTICLE: Epidemiology and molecular typing of Candida isolates from burn patients
Gupta, N., Haque, A., Lattif, A. A., Narayan, R. P., Mukhopadhyay, G., & Prasad, R. (2004) · Mycopathologia · doi:10.1007/s11046-004-1820-x · Cited by 58
Retracted
Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis
Martinez, M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.515 · Cited by 58
Comparison of four molecular typing methods to assess genetic relatedness of Candida albicans clinical isolates in Taiwan
Chen, K.-W., Lo, H., Lin, Y., & Li, S. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45829-0 · Cited by 57
Competitive Fitness of Fluconazole-Resistant Clinical Candida albicans Strains
Popp, C., Hampe, I. A. I., Hertlein, T., Ohlsen, K., Rogers, P. D., & Morschhäuser, J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00584-17 · Cited by 56
Self-citation
Azole‐resistant Candida spp. – emerging pathogens?
Tobudic, S., Kratzer, C., & Presterl, E. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02146.x · Cited by 57
Ibuprofen reverts antifungal resistance onCandida albicansshowing overexpression of CDR genes
Ricardo, E., Costa‐de‐Oliveira, S., Silva-Dias, A., Guerra, J., Rodrigues, A. G., & Pina‐Vaz, C. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00504.x · Cited by 56
Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG 11 gene
Li-juan, F. E. N. G., Wan, Z., Wang, X., Li, R., & Liu, W. Y. (2010) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.2010.05.007 · Cited by 56
Cross-Resistance of Clinical Isolates of Candida albicans and Candida glabrata to Over-the-Counter Azoles Used in the Treatment of Vaginitis
Cross, E. W., Park, S., & Perlin, D. S. (2000) · Microbial Drug Resistance · doi:10.1089/107662900419474 · Cited by 56
Persistence of Candida species in the respiratory tract of cystic fibrosis patients
Muthig, M., Hebestreit, A., Ziegler, U., Seidler, M. J., & Müller, F. C. (2009) · Medical Mycology · doi:10.3109/13693780802716532 · Cited by 56
Susceptibility Pattern and Molecular Type of Species-Specific Candida in Oropharyngeal Lesions of Indian Human Immunodeficiency Virus-Positive Patients
Lattif, A. A., Banerjee, U., Prasad, R., Biswas, A., Wig, N., Sharma, N., Haque, A., Gupta, N., Baquer, N. Z., & Mukhopadhyay, G. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1260-1262.2004 · Cited by 55
Proteomic Analysis of Azole Resistance in Candida albicans Clinical Isolates
Hooshdaran, M. Z., Barker, K. S., Hilliard, G. M., Kusch, H., Morschhäuser, J., & Rogers, P. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2733-2735.2004 · Cited by 55
Iron deprivation inducesEFG1-mediated hyphal development inCandida albicanswithout affecting biofilm formation
Hameed, S., Prasad, T., Banerjee, D., Chandra, A., Mukhopadhyay, C. K., Goswami, S. K., Lattif, A. A., Chandra, J., Mukherjee, P. K., Ghannoum, M. A., et al. (2008) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2008.00394.x · Cited by 52
Establishing Surrogate Markers for FluconazoleResistance in Candida albicans
Park, S., & Perlin, D. S. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.232 · Cited by 53
Comparative Lipidomics of Azole Sensitive and Resistant Clinical Isolates of Candida albicans Reveals Unexpected Diversity in Molecular Lipid Imprints
Singh, A., & Prasad, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019266 · Cited by 51
Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection
Pais, P., Galocha, M., Viana, R., Cavalheiro, M., Pereira, D., & Teixeira, M. C. (2019) · Microbial Cell · doi:10.15698/mic2019.03.670 · Cited by 54
Membrane raft lipid constituents affect drug susceptibilities of Candida albicans
Prasad, T., Pasrija, R., & Prasad, R. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051219 · Cited by 51
Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms
Nailis, H., Vandenbosch, D., Deforce, D. L. D., Nelis, H. J. C. F., & Coenye, T. (2010) · Research in Microbiology · doi:10.1016/j.resmic.2010.02.004 · Cited by 49
Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
Ribeiro, M. A., & Paula, C. R. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.04.019 · Cited by 49
Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae
Barker, K. S. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg217 · Cited by 48
An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses
Hampe, I. A. I., Friedman, J., Edgerton, M., & Morschhäuser, J. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006655 · Cited by 48
Response of sessile cells to stress: from changes in gene expression to phenotypic adaptation
Coenye, T. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00682.x · Cited by 53
Conjugates of Ciprofloxacin and Levofloxacin with Cell-Penetrating Peptide Exhibit Antifungal Activity and Mammalian Cytotoxicity
Ptaszyńska, N., Gucwa, K., Olkiewicz, K., Heldt, M., Serocki, M., Stupak, A., Martynow, D., Dębowski, D., Gitlin‐Domagalska, A., Lica, J. J., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134696 · Cited by 47
Quantitation of ergosterol content and gene expression profile of ERG11 gene in fluconazole-resistant Candida albicans
Alizadeh, F., Khodavandi, A., & Zalakian, S. (2017) · Current Medical Mycology · doi:10.29252/cmm.3.1.13 · Cited by 45
Accumulation of 3-Ketosteroids Induced by Itraconazole in Azole-Resistant ClinicalCandida albicansIsolates
Marichal, P., Gorrens, J., Laurijssens, L., Vermuyten, K., Hove, C. V., Jeune, L. L., Verhasselt, P., Sanglard, D., Borgers, M. J., Ramaekers, F. C. S., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2663 · Cited by 46
Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans: EFG1 regulates multidrug resistance in Candida albicans
Prasad, T., Hameed, S., Manoharlal, R., Biswas, S., Mukhopadhyay, C. K., Goswami, S. K., & Prasad, R. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00639.x · Cited by 46
Synergism of Voriconazole and Terbinafine against Candida albicans Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis
Weig, M., & Müller, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.966-968.2001 · Cited by 46
RTA2 is involved in calcineurin-mediated azole resistance and sphingoid long-chain base release in Candida albicans
Jia, X. M., Wang, Y., Jia, Y., Gao, P. H., Xu, Y. G., Wang, L., Cao, Y. Y., Cao, Y. B., Zhang, L. X., & Jiang, Y. Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8409-3 · Cited by 45
Mitochondrial Complex I Is a Global Regulator of Secondary Metabolism, Virulence and Azole Sensitivity in Fungi
Bromley, M., Johns, A., Davies, E. A., Fraczek, M. G., Gilsenan, J. M., Kurbatova, N., Keays, M., Kapushesky, M., Gut, M., Gut, I. G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158724 · Cited by 44
Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans
Feng, W., Yang, H. J., Xi, Z., Qiao, Z., Lv, Y., Wang, Y., Ma, Y., Wang, Y., & Wen, C. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0095 · Cited by 45
Occurrence, Distribution, and Polymerase Chain Reaction-Based Detection of Resistance to Sterol Demethylation Inhibitor Fungicides in Populations of Blumeriella jaapii in Michigan
Proffer, T. J., Berardi, R., Ma, Z., Nugent, J. E., Ehret, G. R., McManus, P. S., Jones, A. L., & Sundin, G. W. (2006) · Phytopathology · doi:10.1094/phyto-96-0709 · Cited by 45
Axial ligand modified high valent tin( iv ) porphyrins: synthesis, structure, photophysical studies and photodynamic antimicrobial activities on Candida albicans
Soman, R., Raghav, D., Sujatha, S., Rathinasamy, K., & Arunkumar, C. (2015) · RSC Advances · doi:10.1039/c5ra09343k · Cited by 44
A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains
Kusch, H., Biswas, K., Schwanfelder, S., Engelmann, S., Rogers, P. D., Hecker, M., & Morschhäuser, J. (2004) · Molecular Genetics and Genomics · doi:10.1007/s00438-004-0984-x · Cited by 44
Isogenic Strain Construction and Gene Targeting in Candida dubliniensis
Staib, P., Moran, G. P., Sullivan, D. J., Coleman, D. C., & Morschhäuser, J. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.9.2859-2865.2001 · Cited by 44
Transcriptional Activation and Increased mRNA Stability Contribute to Overexpression of CDR1 in Azole-Resistant Candida albicans
Manoharlal, R., Gaur, N. A., Panwar, S. L., Morschhäuser, J., & Prasad, R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01106-07 · Cited by 43
TheCandida dubliniensis CdCDR1Gene Is Not Essential for Fluconazole Resistance
Moran, G. P., Sullivan, D. J., Morschhäuser, J., & Coleman, D. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2829-2841.2002 · Cited by 42
Evolution of Fluconazole-Resistant Candida albicans Strains by Drug-Induced Mating Competence and Parasexual Recombination
Popp, C., Ramı́rez-Zavala, B., Schwanfelder, S., Krüger, I., & Morschhäuser, J. (2019) · mBio · doi:10.1128/mbio.02740-18 · Cited by 45
Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus
Bowyer, P., Mosquera, J., Anderson, M. J., Birch, M., Bromley, M., & Denning, D. W. (2012) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2012.02575.x · Cited by 41
Identification of CARE ‐2‐negative Candida albicans isolates as Candida dubliniensis
Morschhäuser, J., Ruhnke, M., Michel, S., & Hacker, J. H. (1999) · Mycoses · doi:10.1046/j.1439-0507.1999.00259.x · Cited by 39
Self-citation
Voriconazole and multidrug resistance in Candida albicans
Wakieć, R., Prasad, R., Morschhäuser, J., Barchiesi, F., Borowski, E., & Milewski, S. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01327.x · Cited by 39
Azole Resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the Role of ERG11
Gast, C. E., Júnior, L. R. B., Bruzual, I., & Wong, B. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02287-12 · Cited by 39
Disruption of the Transcriptional Regulator Cas5 Results in Enhanced Killing of Candida albicans by Fluconazole
Vasicek, E. M., Berkow, E. L., Bruno, V. M., Mitchell, A. P., Wiederhold, N. P., Barker, K. S., & Rogers, P. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00064-14 · Cited by 38
The drug transporter MgMfs1 can modulate sensitivity of field strains of the fungal wheat pathogen Mycosphaerella graminicola to the strobilurin fungicide trifloxystrobin
Roohparvar, R., Mehrabi, R., van Nistelrooy, J. G. M., Zwiers, L. H., & Waard, M. A. D. (2008) · Pest Management Science · doi:10.1002/ps.1569 · Cited by 37
Membrane raft lipid constituents affect drug susceptibilities of Candida albicans
Pasrija, R., Prasad, T., & Prasad, R. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331219 · Cited by 37
Multiple cis -Acting Sequences Mediate Upregulation of the MDR1 Efflux Pump in a Fluconazole-Resistant Clinical Candida albicans Isolate
Hiller, D., Stahl, S., & Morschhäuser, J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00196-06 · Cited by 37
Distorted Gold(I)–Phosphine Complexes as Antifungal Agents
Dennis, E. K., Kim, J. H., Parkin, S., Awuah, S. G., & Garneau‐Tsodikova, S. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01436 · Cited by 37
Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals
Watamoto, T., Samaranayake, L. P., Egusa, H., Yatani, H., & Seneviratne, C. J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.030692-0 · Cited by 36
In VitroEffect of Malachite Green on Candida albicans Involves Multiple Pathways and Transcriptional RegulatorsUPC2andSTP2
Dhamgaye, S., Devaux, F., Manoharlal, R., Vandeputte, P., Shah, A. H., Singh, A., Blugeon, C., Sanglard, D., & Prasad, R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-11 · Cited by 35
Antifungal Activities of R-135853, a Sordarin Derivative, in Experimental Candidiasis in Mice
Kamai, Y., Kakuta, M., Shibayama, T., Fukuoka, T., & Kuwahara, S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.52-56.2005 · Cited by 35
Amino Acid Substitutions at the Major Insertion Loop of Candida albicans Sterol 14alpha-Demethylase Are Involved in Fluconazole Resistance
Alvarez-Rueda, N., Fleury, A., Morio, F., Pagniez, F., Gastinel, L. N., & Pape, P. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021239 · Cited by 33
A Novel Mechanism of Fluconazole Resistance Associated with Fluconazole Sequestration in Candida albicans Isolates from a Myelofibrosis Patient
Maebashi, K., Kudoh, M., Nishiyama, Y., Makimura, K., Uchida, K., Mori, T., & Yamaguchi, H. (2002) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2002.tb02702.x · Cited by 33
Dynamic and Heterogeneous Mutations to Fluconazole Resistance in Cryptococcus neoformans
Xu, J., Onyewu, C., Yoell, H. J., Ali, R. Y., Vilgalys, R. J., & Mitchell, T. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.420-427.2001 · Cited by 34
Rationally Designed Transmembrane Peptide Mimics of the Multidrug Transporter Protein Cdr1 Act as Antagonists to Selectively Block Drug Efflux and Chemosensitize Azole-resistant Clinical Isolates of Candida albicans
Maurya, I. K., Thota, C. K., Verma, S. D., Sharma, J., Rawal, M. K., Ravikumar, B., Sen, S., Chauhan, N., Lynn, A. M., Chauhan, V. S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.467159 · Cited by 33
Retracted
Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans
Chen, C.-G., Yang, Y.-L., Tseng, K., Shih, H., Liou, C., Lin, C.-C., & Lo, H. (2009) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.06.003 · Cited by 34
Dynamics ofin vitro acquisition of resistance byCandida parapsilosisto different azoles
Silva, A. P., Costa‐de‐Oliveira, S., Silva-Dias, A., Pina‐Vaz, C., & Rodrigues, A. G. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00508.x · Cited by 35
PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans
Manoharlal, R., Gorantala, J., Sharma, M., Sanglard, D., & Prasad, R. (2009) · Microbiology · doi:10.1099/mic.0.035154-0 · Cited by 30
Identification of a negative regulatory element which regulates basal transcription of a multidrug resistance gene of
Gaur, N. A., Puri, N., Karnani, N., Mukhopadhyay, G., GOSWAMI, S., & PRASAD, R. (2003) · FEMS Yeast Research · doi:10.1016/s1567-1356(03)00204-6 · Cited by 31
Development of Lipo-γ-AA Peptides as Potent Antifungal Agents
Zhang, X., Wang, M., Zhu, X., Peng, Y., Fu, T., Hu, C., Cai, J., & Liao, G. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00595 · Cited by 30
Multidrug-Resistant Transporter Mdr1p-Mediated Uptake of a Novel Antifungal Compound
Sun, N., Li, D., Fonzi, W. A., Li, X. V., Zhang, L., & Calderone, R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01504-13 · Cited by 30
Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis
Liu, X. P., Fan, S., Bai, F., Li, J., & Liao, Q. P. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01539.x · Cited by 30
cDNA microarray analysis of differential gene expression and regulation in clinically drug-resistant isolates of Candida albicans from bone marrow transplanted patients
Xu, Z. Q., Zhang, L., Zhang, J., Cao, Y., Yu, Y.-Y., Wang, D., Ying, K., Chen, W., & Jiang, Y. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2006.03.004 · Cited by 30
Comparison of Results Obtained by Testing with Three Different Agar Media and by the NCCLS M27-A Method for In Vitro Testing of Fluconazole against Candida spp
Rubio, M. C., Gil, J., de Ocáriz, I. R., Benito, R., & Rezusta, A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.6.2665-2668.2003 · Cited by 29
A system for studying genetic changes in Candida albicans during infection
Forche, A., May, G., Beckerman, J. L., Kauffman, S., Becker, J. M., & Magee, P. T. (2003) · Fungal Genetics and Biology · doi:10.1016/s1087-1845(02)00585-6 · Cited by 29
Discovery of Synthetic Penaeidin Activity against Antibiotic‐resistant Fungi
Cuthbertson, B. J., Büllesbach, E. E., & Gross, P. S. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00417.x · Cited by 28
The Diversity and Importance of Microbial Cytochromes P450
Kelly, S. L., Kelly, D. E., Jackson, C. J., Warrilow, A. G. S., & Lamb, D. C. (2007) · Springer eBooks · doi:10.1007/0-387-27447-2_13 · Cited by 28
Self-citation
Transcription initiation of genes associated with azole resistance in Candida albicans
Harry, J. B., Song, J. L., Lyons, C. N., & White, T. C. (2002) · Medical Mycology · doi:10.1080/mmy.40.1.73.81 · Cited by 28
Characterization of Mechanisms of Fluconazole Resistance in a Candida albicans Isolate from a Japanese Patient with Chronic Mucocutaneous Candidiasis
Kamai, Y., Maebashi, K., Kudoh, M., Makimura, K., Naka, W., Uchida, K., & Yamaguchi, H. (2004) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2004.tb03623.x · Cited by 27
Mechanisms of Antifungal Drug Resistance in Candida Dubliniensis
Coleman, D. C., Moran, G. P., McManus, B. A., & Sullivan, D. J. (2010) · Future Microbiology · doi:10.2217/fmb.10.51 · Cited by 27
Fluconazole and Voriconazole Multidisk Testing of Candida Species for Disk Test Calibration and MIC Estimation
Kronvall, G., & Karlsson, I. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.4.1422-1428.2001 · Cited by 27
Enhanced Susceptibility to Antifungal Oligopeptides in Yeast Strains Overexpressing ABC Multidrug Efflux Pumps
Wakieć, R., Gabriel, I., Prasad, R., Becker, J. M., Payne, J. W., & Milewski, S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01648-07 · Cited by 26
In Vitro and In Vivo Activities of CS-758 (R-120758), a New Triazole Antifungal Agent
Kamai, Y., Harasaki, T., Fukuoka, T., Ohya, S., Uchida, K., Yamaguchi, H., & Kuwahara, S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.367-370.2002 · Cited by 27
Rifampicin induces MDR1 expression in Candida albicans
Vogel, M., Hartmann, T., Köberle, M., Treiber, M. K., Autenrieth, I. B., & Schumacher, U. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm513 · Cited by 26
SAGA/ADA Complex Subunit Ada2 Is Required for Cap1- but Not Mrr1-Mediated Upregulation of the Candida albicans Multidrug Efflux Pump MDR1
Ramírez-Zavala, B., Mogavero, S., Schöller, E., Sasse, C., Rogers, P. D., & Morschhäuser, J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03065-14 · Cited by 25
Doxorubicin induces drug efflux pumps inCandida albicans
Kofla, G., Turner, V., Schulz, B., Storch, U., Froelich, D., Rognon, B., Coste, A. T., Sanglard, D., & Ruhnke, M. (2010) · Medical Mycology · doi:10.3109/13693786.2010.512022 · Cited by 25
Self-citation
Vitamin D3 a new drug against Candida albicans
Djihane, B., Merzouki, S., Bachiri, M., Ailane, S. E., & Zerroug, M. M. (2016) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2016.10.003 · Cited by 24
Heterologous expression and characterization of the sterol 14α-demethylase CYP51F1 from Candida albicans
Park, H., Lee, I., Chun, Y., Yun, C., Johnston, J. B., de Montellano, P. R. O., & Kim, D. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.02.002 · Cited by 25
A single SNP, G929T (Gly310Val), determines the presence of a functional and a non-functional allele of HIS4 in Candida albicans SC5314: Detection of the non-functional allele in laboratory strains
Gómez‐Raja, J., Andaluz, E., Magee, B. B., Calderone, R., & Larriba, G. (2007) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2007.08.008 · Cited by 24
Induction of Candida albicans Drug Resistance Genes by Hybrid Zinc Cluster Transcription Factors
Schneider, S., & Morschhäuser, J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04448-14 · Cited by 23
Novel Regulatory Mechanisms of Pathogenicity and Virulence to Combat MDR inCandida albicans
Hameed, S., & Fatima, Z. (2013) · International Journal of Microbiology · doi:10.1155/2013/240209 · Cited by 24
Structural basis for heterogeneous phenotype of ERG11 dependent Azole resistance in C.albicans clinical isolates
Debnath, S., & Addya, S. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-660 · Cited by 24
Cerulenin Analogues as Inhibitors of Efflux Pumps in Drug‐resistant Candida albicans
Diwischek, F., Morschhäuser, J., & Holzgrabe, U. (2009) · Archiv der Pharmazie · doi:10.1002/ardp.200800160 · Cited by 24
Development of a new real-time TaqMan PCR assay for quantitative analyses of Candida albicans resistance genes expression
Kofla, G., & Ruhnke, M. (2006) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2006.07.011 · Cited by 24
Self-citation
ZnO Quantum Dots: Broad Spectrum Microbicidal Agent Against Multidrug Resistant Pathogens E. coli and C. albicans
Preeti, P., Radhakrishnan, V. S., Mukherjee, S., Mukherjee, S., Singh, S. P., & Prasad, T. (2020) · Frontiers in Nanotechnology · doi:10.3389/fnano.2020.576342 · Cited by 23
Synergism of Zinc Oxide Quantum Dots with Antifungal Drugs: Potential Approach for Combination Therapy against Drug Resistant Candida albicans
Chand, P., Kumari, S., Mondal, N., Singh, S. P., & Prasad, T. (2021) · Frontiers in Nanotechnology · doi:10.3389/fnano.2021.624564 · Cited by 23
Magnesium deprivation affects cellular circuitry involved in drug resistance and virulence in Candida albicans
Hans, S., Fatima, Z., & Hameed, S. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.01.011 · Cited by 22
Fcr1p Inhibits Development of Fluconazole Resistance in Candida albicans by Abolishing CDR1 Induction
Shen, H., An, M., Wang, D. J., Xu, Z. Q., Zhang, J., Gao, P., Cao, Y., Cao, Y., & Jiang, Y. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.68 · Cited by 23
Gene regulation and host adaptation mechanisms in Candida albicans
Staib, P., Wirsching, S., Strauß, A., & Morschhäuser, J. (2001) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00114 · Cited by 23
Trends in Antifungal Susceptibility among Candida sp. Urinary Isolates from 1994 and 1998
Baran, J., Klauber, E., Barczak, J., RIEDERER, K. M., & Khatib, R. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.870-871.2000 · Cited by 22
Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element
Gaur, N. A., Manoharlal, R., Saini, P., Prasad, T., Mukhopadhyay, G., Hoefer, M., Morschhäuser, J., & Prasad, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.113 · Cited by 22
Vaginitis: Review on Drug Resistance
Rigo, G. V., & Tasca, T. (2020) · Current Drug Targets · doi:10.2174/1389450121666200804112340 · Cited by 23

Authors: Franz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M., & Morschhäuser, J.
Affiliations: University of Würzburg (DE)
Aberystwyth University (GB)
Humboldt-Universität zu Berlin (DE)
Zentrum für Infektionsforschung, Universität Würzburg, D-97070 Würzburg,1 and
ORCID: Kelly, Steven L.
Lamb, David C.
Kelly, Diane E.
Ruhnke, Markus
Venue: Antimicrobial Agents and Chemotherapy
Publisher: American Society for Microbiology
Published: 1998-12
Volume: 42
Issue: 12
Pages: 3065-3072
ISSN: 0066-4804 (ISSN-L)
1098-6596
DOI: 10.1128/aac.42.12.3065
PMC: PMC106000
OpenAlex: W2160765565
Cited by: 339
References: 38
Citations by year: 2026: 6 · 2025: 4 · 2024: 7 · 2023: 9 · 2022: 4 · 2021: 11 · 2020: 14 · 2019: 15 · 2018: 8 · 2017: 14 · 2016: 11 · 2015: 10 · 2014: 16 · 2013: 12 · 2012: 7
FWCI: 9.08
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Antimicrobial Agents and Chemotherapy (publishedVersion)
PubMed Central (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed (publishedVersion)
Funders: Bundesministerium für Bildung und Forschung
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords: Candida albicans, fluconazole resistance, oropharyngeal candidiasis, AIDS, MDR1 gene, ERG11, sterol 14α-demethylase, major facilitator superfamily, drug accumulation, microevolution, recurrent infections, antifungal resistance mechanisms
MeSH terms: Alleles, Antifungal Agents, Candida albicans, Candidiasis, Cytochrome P-450 Enzyme System, Drug Resistance, Microbial, Gene Expression Regulation, Humans, Gas Chromatography-Mass Spectrometry, Microbial Sensitivity Tests, Nucleic Acid Hybridization, Oxidoreductases, RNA, Bacterial, Blotting, Southern, Blotting, Northern, Fluconazole, AIDS-Related Opportunistic Infections, Genes, MDR, Sterol 14-Demethylase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical Candida albicans Strains

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks